|
|
| Division of Endocrinology, Diabetes and Metabolism |
|
RESEARCH ACTIVITIES
Research activities focus on outcomes of care in diabetes, clinical research in thyroid cancer, molecular pathogenesis of thyroid cancer and diabetes drug studies as follows.
Multicenter Trials
1. Exanatide for Type 2 DM
2. Glimeperide vs. Metformin in Type 2 DM in children
3. Ertapenem in Diabetic Foot
4. Rosiglitazone in Type 2 DM (beta cell preservation)
5. Glargine vs. TZDs in Type 2 DM
6. Pioglitazone in atherosclerosis
7. NAPH Diabetes Studies (with Dr.Reilly)
Studies (original and ongoing)
1. Metabolic Syndrome in adolescent Hispanics
2. Motivational Interview for New Diabetics
3. Diabetes burden in CCBHS (with Dr. Shiff group)
4. Accuracy of Home Blood Glucose Monitoring
5. Safety-net therapy for unstable diabetes (with Emergency Department)
6. Asymptomatic ventricular dysfunction in new diabetics (with Div. of Cardiology)
7. The impact of patients diabetes knowledge on outcomes of care
8. High dose of 131 I therapy in Graves' disease
STUDIES IN ADVANCED PLANNING
1. Detection and management of prediabetes and metabolic syndrome-feasibility phase
2. Multifactorial intervention in patient with advanced nephropathy (with Renal Division)
|
| |
| |
|
